Pancreatic cancer
Results
Phase 1/2
This trial looked at a vaccine called TG01 with GM-CSF and gemcitabine for cancer of the pancreas. This trial was for people who had surgery to completely remove their pancreatic cancer.
It was open for people to join between 2013 and 2016. The team presented the results at a conference in 2017 and published the results in 2020.
Recruitment start: 10 December 2013
Recruitment end: 6 May 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Dan Palmer
NIHR Clinical Research Network: Cancer
Targovax A/S
Last reviewed: 11 Aug 2021
CRUK internal database number: 11768
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
